Els A J M Goulmy

Title: Innovations by Els A J M Goulmy

Introduction

Els A J M Goulmy is a prominent inventor based in Oegstgeest, Netherlands. She has made significant contributions to the field of immunology, particularly in the development of peptides related to minor histocompatibility antigens. With a total of four patents to her name, Goulmy's work has important implications for transplantation medicine.

Latest Patents

Goulmy's latest patents include the HA-1 antigen, which is a peptide sequence associated with Graft versus Host disease. This peptide and its derivatives are crucial in bone marrow and organ transplantation, as well as in the treatment of leukemia. The peptide, derived from the HA-1 minor antigen, has the sequence VLXDDLLEA, where X represents a histidine or arginine residue. Both donors and recipients in bone marrow transplantation can benefit from these peptides, which can be combined with other peptides and suitable excipients or adjuvants. Another significant patent is related to the H-Y antigen, which involves a peptide that serves as a T cell epitope of the minor Histocompatibility antigen H-Y. This peptide can induce tolerance for transplantations when administered to H-Y-negative recipients.

Career Highlights

Goulmy is affiliated with Rijksuniversiteit Te Leiden, where she continues her research and innovation in the field of immunology. Her work has been instrumental in advancing the understanding of minor histocompatibility antigens and their applications in medical treatments.

Collaborations

Goulmy has collaborated with notable colleagues such as Donald F Hunt and Victor H Engelhard, contributing to the advancement of research in her field.

Conclusion

Els A J M Goulmy's innovative work in peptide development has made a significant impact on transplantation medicine. Her contributions continue to pave the way for advancements in immunology and patient care.